Antibacterial flavonoids against oral bacteria of Enterococcus faecalis ATCC 29212 from Sarang Semut (Myrmecodia pendans) and its inhibitor activity against …
D Kurnia, E Apriyanti, C Soraya… - Current Drug Discovery …, 2019 - ingentaconnect.com
Background: A significant number of antibiotics are known to inhibit peptidoglycan synthesis
in the cross-linking stage, while the drug fosfomycin is the only one known to inhibit MurA …
in the cross-linking stage, while the drug fosfomycin is the only one known to inhibit MurA …
Aktifitas Antibakteri Terpenoid dari Umbi Sarang Semut (Myrmecodia pendens) Terhadap Streptococcus Sanguinis ATCC10556
FA Attamimi, IP Yuda - Yarsi Journal of Pharmacology, 2022 - academicjournal.yarsi.ac.id
Latar belakang: Streptococcus sanguinis dapat memfasilitasi perlekatan bakteri patogen
penyebab periodontitis dan menjadi salah satu organisme penyebab endokarditits infektif …
penyebab periodontitis dan menjadi salah satu organisme penyebab endokarditits infektif …
[PDF][PDF] Antibacterial diterpenoid against pathogenic oral bacteria of Streptococcus mutans ATCC 25175 isolated from Sarang Semut (Myrmecodia pendans)
MH Satari, B Situmeang, IP Yudha… - Jurnal Kimia …, 2019 - pdfs.semanticscholar.org
Discovery of new antibacterial agent to treat oral disease caused by pathogenic oral
bacteria is an attracted focus to more pay attention of researcher. The tropical natural …
bacteria is an attracted focus to more pay attention of researcher. The tropical natural …